Our data showed that there is no obvious difference of phospho-PLC-γ1 and phospho-c-jun, while the phosphorylated NF-κB p65: NF-κB p65 ratio was developed in 2 of 4 DLBCL patients (data not shown). This evidence concerns the gene JUN and diffuse large B-cell lymphoma.